-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Have AdaptHealth Corp. (NASDAQ:AHCO) Insiders Been Selling Their Stock?
Have AdaptHealth Corp. (NASDAQ:AHCO) Insiders Been Selling Their Stock?
We wouldn't blame AdaptHealth Corp. (NASDAQ:AHCO) shareholders if they were a little worried about the fact that Wayne Quasha, a company insider, recently netted about US$4.0m selling shares at an average price of US$20.00. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 1.4%.
See our latest analysis for AdaptHealth
The Last 12 Months Of Insider Transactions At AdaptHealth
Notably, that recent sale by insider Wayne Quasha was not the only time they sold AdaptHealth shares this year. They previously made an even bigger sale of -US$18m worth of shares at a price of US$21.50 per share. That means that even when the share price was slightly below the current price of US$21.72, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. This single sale was just 5.8% of Wayne Quasha's stake.
Happily, we note that in the last year insiders paid US$524k for 33.93k shares. On the other hand they divested 2.30m shares, for US$49m. All up, insiders sold more shares in AdaptHealth than they bought, over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
I will like AdaptHealth better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Insider Ownership Of AdaptHealth
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. AdaptHealth insiders own 18% of the company, currently worth about US$525m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Does This Data Suggest About AdaptHealth Insiders?
Insiders sold AdaptHealth shares recently, but they didn't buy any. Despite some insider buying, the longer term picture doesn't make us feel much more positive. But since AdaptHealth is profitable and growing, we're not too worried by this. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 3 warning signs for AdaptHealth (of which 1 is a bit concerning!) you should know about.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
我们不会责怪AdaptHealth Corp.纳斯达克(Sequoia Capital:AHCO)股东如果对公司内部人士韦恩·夸沙最近以平均20美元的价格出售股票净赚约400万美元感到有点担忧。然而,重要的是要注意到,他们仍然非常多地投资于股票,出售只减少了1.4%的持有量。
查看我们对AdaptHealth的最新分析
AdaptHealth最近12个月的内幕交易
值得注意的是,内部人士韦恩·夸沙最近的出售并不是他们今年唯一次出售AdaptHealth股票。此前,他们以每股21.5美元的价格出售了价值1800万美元的股票,规模更大。这意味着,即使股价略低于目前21.72美元的价格,一名内部人士也想套现一些股票。当内部人士以低于当前价格的价格出售股票时,这表明他们认为较低的价格是公平的。这让我们想知道他们对最近(较高的)估值有何看法。然而,请注意,卖家可能有各种各样的理由出售,所以我们不能确切地知道他们对股价的看法。这笔交易仅占韦恩·夸沙所持股份的5.8%。
令人高兴的是,我们注意到,在去年,内部人士支付了52.4万美元购买了339.3万股。另一方面,他们以4900万美元的价格剥离了230万股票。总而言之,在过去一年里,内部人士卖出的AdaptHealth股票多于他们购买的股票。下面的图表显示了过去一年的内幕交易(按公司和个人)。通过点击下面的图表,你可以看到每一笔内幕交易的准确细节!
如果我看到一些内部人士大举收购,我会更喜欢AdaptHealth。在我们等待的时候,看看这个免费最近有大量内幕收购的成长型公司名单。
AdaptHealth的内部所有权
看看一家公司的内部人持股总数,可以帮助你了解他们是否与普通股股东很好地结合在一起。我认为,如果内部人士持有该公司大量股份,这是一个好兆头。AdaptHealth内部人士拥有该公司18%的股份,根据最近的股价,目前价值约为5.25亿美元。大多数股东将乐于看到这种内部人持股,因为这表明管理层的激励与其他股东很好地结合在一起。
那么,这些数据对AdaptHealth内部人士有什么启示呢?
内部人士最近抛售了AdaptHealth的股票,但他们没有买入任何股票。尽管有一些内部人士买入,但更长期的前景并没有让我们感觉更积极。但由于AdaptHealth是盈利的,而且还在增长,我们并不太担心这一点。虽然内部人士确实持有该公司的大量股份(这很好),但我们对他们交易的分析并不能让我们对该公司充满信心。虽然我们喜欢知道内部人士的所有权和交易情况,但在做出任何投资决定之前,我们也要确保考虑到一只股票面临的风险。每家公司都有风险,我们已经发现AdaptHealth的3个警告标志(其中1个有点令人担忧!)你应该知道。
当然了,如果你把目光投向别处,你可能会发现这是一笔很棒的投资。所以让我们来看看这个免费有趣的公司名单。
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前负责公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有什么反馈吗?担心内容吗?保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧